135 related articles for article (PubMed ID: 28186976)
1. 32-Phosphorus selectively delivered by listeria to pancreatic cancer demonstrates a strong therapeutic effect.
Chandra D; Selvanesan BC; Yuan Z; Libutti SK; Koba W; Beck A; Zhu K; Casadevall A; Dadachova E; Gravekamp C
Oncotarget; 2017 Mar; 8(13):20729-20740. PubMed ID: 28186976
[TBL] [Abstract][Full Text] [Related]
2.
Selvanesan BC; Chandra D; Quispe-Tintaya W; Jahangir A; Patel A; Meena K; Alves Da Silva RA; Friedman M; Gabor L; Khouri O; Libutti SK; Yuan Z; Li J; Siddiqui S; Beck A; Tesfa L; Koba W; Chuy J; McAuliffe JC; Jafari R; Entenberg D; Wang Y; Condeelis J; DesMarais V; Balachandran V; Zhang X; Lin K; Gravekamp C
Sci Transl Med; 2022 Mar; 14(637):eabc1600. PubMed ID: 35320003
[TBL] [Abstract][Full Text] [Related]
3. Nontoxic radioactive Listeria(at) is a highly effective therapy against metastatic pancreatic cancer.
Quispe-Tintaya W; Chandra D; Jahangir A; Harris M; Casadevall A; Dadachova E; Gravekamp C
Proc Natl Acad Sci U S A; 2013 May; 110(21):8668-73. PubMed ID: 23610422
[TBL] [Abstract][Full Text] [Related]
4. The effect of various therapeutic solutions including colloidal chromic 32P via an intratumoral injection on the tumor physiological parameters of AsPC-1 human pancreatic tumor xenografts in nude mice.
Lee I; Lee YH
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3139s-3142s. PubMed ID: 10541354
[TBL] [Abstract][Full Text] [Related]
5. A Novel Immunocompetent Mouse Model of Pancreatic Cancer with Robust Stroma: a Valuable Tool for Preclinical Evaluation of New Therapies.
Majumder K; Arora N; Modi S; Chugh R; Nomura A; Giri B; Dawra R; Ramakrishnan S; Banerjee S; Saluja A; Dudeja V
J Gastrointest Surg; 2016 Jan; 20(1):53-65; discussion 65. PubMed ID: 26582596
[TBL] [Abstract][Full Text] [Related]
6. Complete tumor response following intratumoral 32P BioSilicon on human hepatocellular and pancreatic carcinoma xenografts in nude mice.
Zhang K; Loong SL; Connor S; Yu SW; Tan SY; Ng RT; Lee KM; Canham L; Chow PK
Clin Cancer Res; 2005 Oct; 11(20):7532-7. PubMed ID: 16243828
[TBL] [Abstract][Full Text] [Related]
7. Conjugation to the sigma-2 ligand SV119 overcomes uptake blockade and converts dm-Erastin into a potent pancreatic cancer therapeutic.
Ohman KA; Hashim YM; Vangveravong S; Nywening TM; Cullinan DR; Goedegebuure SP; Liu J; Van Tine BA; Tiriac H; Tuveson DA; DeNardo DG; Spitzer D; Mach RH; Hawkins WG
Oncotarget; 2016 Jun; 7(23):33529-41. PubMed ID: 27244881
[TBL] [Abstract][Full Text] [Related]
8. Design and bioevaluation of a 32P-patch for brachytherapy of skin diseases.
Salgueiro MJ; Durán H; Palmieri M; Pirchio R; Nicolini J; Ughetti R; Papparella ML; Casale G; Zubillaga M
Appl Radiat Isot; 2008 Mar; 66(3):303-9. PubMed ID: 17954028
[TBL] [Abstract][Full Text] [Related]
9. Targeted delivery of chemotherapy using HSP90 inhibitor drug conjugates is highly active against pancreatic cancer models.
Bobrov E; Skobeleva N; Restifo D; Beglyarova N; Cai KQ; Handorf E; Campbell K; Proia DA; Khazak V; Golemis EA; Astsaturov I
Oncotarget; 2017 Jan; 8(3):4399-4409. PubMed ID: 27779106
[TBL] [Abstract][Full Text] [Related]
10. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
[TBL] [Abstract][Full Text] [Related]
11. A bioluminescent mouse model of proliferation to highlight early stages of pancreatic cancer: A suitable tool for preclinical studies.
de Latouliere L; Manni I; Iacobini C; Pugliese G; Grazi GL; Perri P; Cappello P; Novelli F; Menini S; Piaggio G
Ann Anat; 2016 Sep; 207():2-8. PubMed ID: 26704357
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase-9 (MMP-9) as an activator of nanosystems for targeted drug delivery in pancreatic cancer.
Grünwald B; Vandooren J; Locatelli E; Fiten P; Opdenakker G; Proost P; Krüger A; Lellouche JP; Israel LL; Shenkman L; Comes Franchini M
J Control Release; 2016 Oct; 239():39-48. PubMed ID: 27545397
[TBL] [Abstract][Full Text] [Related]
13. Tumour-specific delivery of siRNA-coupled superparamagnetic iron oxide nanoparticles, targeted against PLK1, stops progression of pancreatic cancer.
Mahajan UM; Teller S; Sendler M; Palankar R; van den Brandt C; Schwaiger T; Kühn JP; Ribback S; Glöckl G; Evert M; Weitschies W; Hosten N; Dombrowski F; Delcea M; Weiss FU; Lerch MM; Mayerle J
Gut; 2016 Nov; 65(11):1838-1849. PubMed ID: 27196585
[TBL] [Abstract][Full Text] [Related]
14. Regression of HPV-positive tumors treated with a new Listeria monocytogenes vaccine.
Sewell DA; Douven D; Pan ZK; Rodriguez A; Paterson Y
Arch Otolaryngol Head Neck Surg; 2004 Jan; 130(1):92-7. PubMed ID: 14732776
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic and therapeutic efficacy of an attenuated Listeria monocytogenes-based vaccine delivering HPV16 E7 in a mouse model.
Jia Y; Yin Y; Duan F; Fu H; Hu M; Gao Y; Pan Z; Jiao X
Int J Mol Med; 2012 Dec; 30(6):1335-42. PubMed ID: 23027427
[TBL] [Abstract][Full Text] [Related]
16. Listeria-based cancer vaccines that segregate immunogenicity from toxicity.
Brockstedt DG; Giedlin MA; Leong ML; Bahjat KS; Gao Y; Luckett W; Liu W; Cook DN; Portnoy DA; Dubensky TW
Proc Natl Acad Sci U S A; 2004 Sep; 101(38):13832-7. PubMed ID: 15365184
[TBL] [Abstract][Full Text] [Related]
17. Intratumoral injection of 32P-chromic phosphate in the treatment of implanted pancreatic carcinoma.
Gao W; Liu L; Liu ZY; Wang Y; Jiang B; Liu XN
Cancer Biother Radiopharm; 2010 Apr; 25(2):215-24. PubMed ID: 20423235
[TBL] [Abstract][Full Text] [Related]
18. Phospho-Aspirin (MDC-22) Prevents Pancreatic Carcinogenesis in Mice.
Mattheolabakis G; Papayannis I; Yang J; Vaeth BM; Wang R; Bandovic J; Ouyang N; Rigas B; Mackenzie GG
Cancer Prev Res (Phila); 2016 Jul; 9(7):624-34. PubMed ID: 27138793
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of cellular uptake, tumor retention, radiation response, and tumor pathophysiology in experimental solid tumors after an intratumoral infusion of colloidal 32P.
Lee I; Wallner PE
Cancer; 1997 Dec; 80(12 Suppl):2611-7. PubMed ID: 9406715
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological macrophage inhibition decreases metastasis formation in a genetic model of pancreatic cancer.
Griesmann H; Drexel C; Milosevic N; Sipos B; Rosendahl J; Gress TM; Michl P
Gut; 2017 Jul; 66(7):1278-1285. PubMed ID: 27013602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]